Internal Medicine, Rheumatology · Jersey City, NJ
NPI
1770523433
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
600 Pavonia Ave
Jersey City, NJ, 07306
Phone (201) 216-3050
Groups this clinician bills Medicare through
Medicare paid, 2024
$178K
17,227 services
Medicare patients, 2024
294
Average age 74
Drug cost, 2024
$3.6M
3,351 prescriptions
Company payments, 2025
$21K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nicholas P Scarpa was code J1010 (injection, methylprednisolone acetate, 1 mg), 14,100 times for 136 patients. In total Nicholas P Scarpa billed 17,227 services in 14 codes, and Medicare paid $178K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-10-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 14,100 | 136 | $0.10 | $1,435 |
| J0897 Injection, denosumab, 1 mg | Office | 1,260 | 14 | $20.58 | $26K |
| 99213 Office E&M - Established | Office | 705 | 225 | $77.53 | $55K |
| 20610 Joint Injection | Office | 513 | 159 | $76.16 | $39K |
| 99214 Office E&M - Established | Office | 391 | 157 | $109.71 | $43K |
| J1030 Injection, methylprednisolone acetate, 40 mg | Office | 132 | 93 | $4.20 | $554 |
| 99204 Office E&M - New | Office | 52 | 52 | $146.39 | $7,612 |
| 96401 Chemotherapy Administration | Office | 30 | 21 | $64.55 | $1,936 |
| 99212 Office E&M - Established | Office | 14 | 12 | $47.48 | $665 |
By year: 2022 $188K for 3,696 services; 2023 $170K for 3,170 services; 2024 $178K for 17,227 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nicholas P Scarpa prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 356 prescriptions and refills. In total Nicholas P Scarpa wrote 3,351 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 356 | 457 | 58 | $14K |
| Methylprednisolone Generic | 295 | 367 | 99 | $3,486 |
| Methotrexate Methotrexate Sodium | 267 | 367 | 45 | $6,176 |
| Prednisone Generic | 239 | 304 | 44 | $962 |
| Diclofenac Sodium Generic | 225 | 278 | 78 | $13K |
| Sulindac Generic | 185 | 213 | 65 | $2,856 |
| Meloxicam Generic | 148 | 173 | 44 | $828 |
| Leflunomide Generic | 147 | 248 | 32 | $7,964 |
| Rinvoq Upadacitinib | 106 | 122 | 15 | $765K |
| Azathioprine Generic | 98 | 125 | 15 | $2,369 |
| Celecoxib Generic | 90 | 116 | 28 | $2,017 |
| Enbrel Sureclick Etanercept | 88 | 90 | Under 11 | $693K |
| Nabumetone Generic | 82 | 101 | 26 | $904 |
| Tizanidine Hcl Generic | 75 | 93 | 20 | $388 |
| Gabapentin Generic | 74 | 76 | 19 | $607 |
Brand drugs: 541 claims; generic drugs: 2,810 claims; opioid claims: 26.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nicholas P Scarpa $21K ($21K in general payments such as food, travel and fees) from 11 companies. The largest payer was Abbvie Inc. with $19K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 38 | $19K |
| Novartis Pharmaceuticals Corporation NVS | 11 | $457 |
| Janssen Biotech, Inc. JNJ | 12 | $289 |
| Pfizer Inc. PFE | 13 | $222 |
| E.R. Squibb & Sons, L.L.C. BMY | 15 | $196 |
| Mallinckrodt Hospital Products Inc. | 1 | $135 |
| Amgen Inc. AMGN | 8 | $135 |
| UCB, Inc. UCB.BR | 4 | $65.27 |
| Genzyme Corporation SNY | 2 | $32.3 |
| GlaxoSmithKline, LLC. GSK | 2 | $28.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.